Lol.
A lot of small caps being ignored at the moment .
No big deal .... the value in CHM will get noticed eventually ( for reasons already expressed )
Capitalise on the opportunity to add a few more ...... and a few more .. and just a few more.
Don't worry about the day to day price .
R&D is slow as u well know .
Risk to reward scenario @ these levels looks sensational .
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
